PDE5A and esophageal squamous cell carcinoma: The clinical correlation and KM survival analyses showed that low PDE5A-500aa expression was associated with the later clinicopathological stages (Fig. S3B–D) and poor prognosis (Fig. 4L) of ESCC patients.